Evolutionary Trends in Viral Pathogens Within and Between Outbreaks

Evolutionary Trends in Viral Pathogens Within and Between Outbreaks

EVOLUTIONARY TRENDS IN VIRAL PATHOGENS WITHIN AND BETWEEN OUTBREAKS A dissertation submitted to Kent State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy by Mary E. Saha December 2017 © Copyright All rights reserved Except for previously published materials Dissertation written by Mary E Saha B.S., University of Akron, 2008 Ph.D., Kent State University, 2017 Approved by _Dr. Helen Piontkivska___________ Chair, Doctoral Dissertation Committee _Dr. Gary Koski_________________ Members, Doctoral Dissertation Committee _Dr. Christopher Woolverton_______ _Dr. Tara Smith_________________ _Dr. Walter Hoeh________________ _Dr. Gail Fraizer_________________ Accepted by __Dr. Laura Leff________________ Chair, Department of Biology __Dr. James Blank_______________ Dean, College of Arts and Sciences Table of Contents LIST OF FIGURES ......................................................................................................... V LIST OF TABLES ........................................................................................................ VII ACKNOWLEDGEMENTS ........................................................................................ VIII CHAPTER 1: INTRODUCTION .................................................................................... 1 1.1 RNA viruses .............................................................................................................. 1 1.2 Influenza A.................................................................................................................... 3 1.3 Challenges in Influenza Sampling ................................................................................ 6 1.4 Ebolavirus ................................................................................................................... 12 1.5 Immune Response against Ebolavirus ........................................................................ 17 1.6 Ebolavirus Outbreaks and Public Health .................................................................... 19 1.7 Ebolavirus Evolutionary Questions ............................................................................ 27 1.8 Research Goals............................................................................................................ 30 1.9 Overview of Subsequent Chapters .............................................................................. 33 1.10 References ................................................................................................................. 35 CHAPTER 2: SAMPLING ISSUES IN INFLUENZA A ANALYSIS: AN APPROACH TO DEALING WITH OVERSAMPLING ............................... 44 2.1 Introduction ............................................................................................................. 44 2.2 Hypotheses .............................................................................................................. 46 2.3 Methods ................................................................................................................... 46 2.4 Results ..................................................................................................................... 50 2.5 Discussion and Conclusions .................................................................................... 62 2.6 References ................................................................................................................... 71 iii CHAPTER 3: GENOME-WIDE MOLECULAR SUBSTITUTION PATTERNS IN EBOLAVIRUS .................................................................................................... 76 3.1 Introduction ............................................................................................................. 76 3.2 Hypothesis ............................................................................................................... 77 3.3 Methods ................................................................................................................... 77 3.4 Results ..................................................................................................................... 80 3.5 Discussion and Conclusions .................................................................................. 105 3.6 References ................................................................................................................. 112 CHAPTER 4: DISTRIBUTION OF POSITIVELY AND NEGATIVELY SELECTED SITES IN THE EBOLAVIRUS GENOME ............................. 115 4.1 Introduction ........................................................................................................... 115 4.2 Hypotheses ............................................................................................................ 116 4.3 Methods ................................................................................................................. 117 4.4 Results ................................................................................................................... 120 4.5 Discussion and Conclusions .................................................................................. 137 4.6 References ................................................................................................................. 146 CHAPTER 5: SUMMARY AND FUTURE DIRECTIONS ..................................... 150 References ....................................................................................................................... 163 APPENDICES ............................................................................................................... 171 Chapter 1 ......................................................................................................................... 171 Chapter 2 ......................................................................................................................... 173 Chapter 3 ......................................................................................................................... 176 Chapter 4 ......................................................................................................................... 199 iv List of Figures Figure 1.1: Synonymous substitution rates in RNA viruses ............................................... 2 Figure 1.2: Percentages of HA Influenza A sequences available for the top ten countries (or territories) in the NCBI Influenza Database (2013). ..................................................... 8 Figure 1.3: The number of publications in PubMed for Influenza A and Ebolavirus by date .................................................................................................................................... 11 Figure 1.4: Infection Progression of Ebolavirus. .............................................................. 14 Figure 1.5: Ebolavirus life cycle and immune system effects .......................................... 17 Figure 1.6: Map of 2014 outbreak with the number of cases ........................................... 22 Figure 1.7: Map of the 2017 outbreak in the Democratic Republic of the Congo (DRC, formerly Zaire) .................................................................................................................. 24 Figure 2.1: Workflow of analysis steps. ........................................................................... 49 Figure 2.2: dN Values by Country and Year: ................................................................... 52 Figure 2.3: dS Values by Country and Year: .................................................................... 53 Figure 2.4: Nucleotide Diversity Values. ........................................................................ 57 Figure 2.5: dN Values. ...................................................................................................... 59 Figure 2.6: dS Values:....................................................................................................... 61 Figure 2.7: dN/dS values by number of sequences used and color coded by the source article................................................................................................................................. 69 Figure 3.1: Phylogenetic Tree of Ebolavirus Sequences .................................................. 89 Figure 3.2: Phylogenetic pairs mean dN. .......................................................................... 90 v Figure 3.3: Phylogenetic pairs mean dS. .......................................................................... 92 Figure 3.4: GP Between Pairs dN. .................................................................................... 94 Figure 3.5: GP Within Pairs dN. ....................................................................................... 96 Figure 3.6: Phylogenetic pairs within group values.......................................................... 98 Figure 3.7: 2014 outbreak dN-dS values for within phylogenetic pair comparisons. ... 100 Figure 3.8: Other outbreak dN-dS values for within phylogenetic pair comparisons. ... 102 Figure 3.9: GP 50% epitope dN-dS. ............................................................................... 104 Figure 4.1: Epitope Regions and Polymorphic Sites in Three Ebolavirus Genes .......... 121 Figure 4.2: Epitope Regions and Polymorphic Sites in Three Ebolavirus Genes .......... 123 Figure 4.3: Epitope Regions and Polymorphic Sites in Three Ebolavirus Genes .......... 125 Figure 4.4: Protein Structures and Polymorphic Sites in Six Ebolavirus

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    210 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us